BC Women’s Research Rounds: PErsonalized Genomics for prenatal Aneuploidy Screening USing maternal blood: Lessons Learned & Questions to be Answered

Presenter: Dr Sylvie Langlois, MD, FRCPC, FCCMG

Date: January 19th, 2018

Time: 8:00am – 9:00am

Location: Room D308 Shaughnessy Building

Goals/Learning Objectives:

Review the approaches and performance of cfDNA screening tests for common aneuploidy.
Demonstrate the impact of second tier cfDNA screening.
Discuss questions to be answered by ongoing research in this filed.

Videoconferencing Sites
UBC Okanagan	VC: UBCO	RHS 129
Vancouver General Hospital	VC: VGH	DHCC 2262
Northern BC	VC: UHNBC	UHNBC 5005
Northern BC	VC: ARC	MMH 1020

The Women’s Health Research Institute would like to acknowledge that we are uninvited guests on the unceded ancestral territories of the xʷməθkwəy̓əm (Musqueam), Skwxwú7mesh (Squamish), Stó:lo, and sel̓íl̓witulh (Tsleil-waututh) Nations.

As a provincial research institute committed to improving the health outcomes of women, including those across the 2SLGBTQIA+ spectrum, we recognize our responsibility in the collective effort towards establishing culturally safe health care systems and services that address health inequities among Indigenous peoples, especially Indigenous women, girls, and Two-spirit peoples.

We encourage all people involved in research to read both the Truth and Reconciliation Commission of Canada: Calls to Action and the In Plain Sight Report, and reflect on ways we can incorporate the recommendations into our work. As we gather in spaces together, we encourage you to reflect on your positionality on these lands and your personal commitments to reconciliation.

Top